Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Martini

Showing results (501-510 of 549) with videos related to

Pageof 55
Sort By:
Annals of the Rheumatic Diseases|June 13, 2012
Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative studyJoachim Gerss, Johannes Roth, Dirk Holzinger, et al.
The Journal of Rheumatology|August 1, 2024
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III StudyHermine I Brunner, César Pacheco-Tena, Ingrid Louw, et al.
BJU International|March 13, 2026
Risk stratification and conditional recurrence after radical cystectomy: toward adaptive follow-upRoberto Contieri, Alberto Martini, Marc Furrer, et al.
The Journal of Rheumatology|March 3, 2016
Two-year Efficacy and Safety of Etanercept in Pediatric Patients with Extended Oligoarthritis, Enthesitis-related Arthritis, or Psoriatic ArthritisTamas Constantin, Ivan Foeldvari, Jelena Vojinovic, et al.
Prostate Cancer and Prostatic Diseases|November 5, 2024
Follow-up on patients with initial negative mpMRI target and systematic biopsy for PI-RADS ≥ 3 lesions - an EAU-YAU study enhancing prostate cancer detectionFabio Zattoni, Giorgio Gandaglia, Roderick C N van den Bergh, et al.
European Urology Oncology|June 21, 2024
Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer: A Framework Based on Expert Practices Collaboratively Developed by the European Association of Urology Bladder Cancer Guideline PanelsLaura S Mertens, Harman Maxim Bruins, Roberto Contieri, et al.
Arthritis and Rheumatism|March 2, 2010
Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritisNicolino Ruperto, Daniel J Lovell, Pierre Quartier, et al.
Annals of the Rheumatic Diseases|June 7, 2024
Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension studyHermine I Brunner, Jonathan D Akikusa, Eslam Al-Abadi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 3, 2018
IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic ArthritisVictoria L Arthur, Emily Shuldiner, Elaine F Remmers, et al.
Minerva Urology and Nephrology|September 25, 2024
Oncologic surveillance after surgical treatment for clinically localized kidney cancer: UroCCR study n. 129Alberto Martini, Jean-Christophe Bernhard, Ugo G Falagario, et al.
Pageof 55

Showing results (501-510 of 549) with videos related to

Sort By:
Pageof 55
Annals of the Rheumatic Diseases|June 13, 2012
Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative studyJoachim Gerss, Johannes Roth, Dirk Holzinger, et al.
The Journal of Rheumatology|August 1, 2024
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III StudyHermine I Brunner, César Pacheco-Tena, Ingrid Louw, et al.
BJU International|March 13, 2026
Risk stratification and conditional recurrence after radical cystectomy: toward adaptive follow-upRoberto Contieri, Alberto Martini, Marc Furrer, et al.
The Journal of Rheumatology|March 3, 2016
Two-year Efficacy and Safety of Etanercept in Pediatric Patients with Extended Oligoarthritis, Enthesitis-related Arthritis, or Psoriatic ArthritisTamas Constantin, Ivan Foeldvari, Jelena Vojinovic, et al.
Prostate Cancer and Prostatic Diseases|November 5, 2024
Follow-up on patients with initial negative mpMRI target and systematic biopsy for PI-RADS ≥ 3 lesions - an EAU-YAU study enhancing prostate cancer detectionFabio Zattoni, Giorgio Gandaglia, Roderick C N van den Bergh, et al.
European Urology Oncology|June 21, 2024
Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer: A Framework Based on Expert Practices Collaboratively Developed by the European Association of Urology Bladder Cancer Guideline PanelsLaura S Mertens, Harman Maxim Bruins, Roberto Contieri, et al.
Arthritis and Rheumatism|March 2, 2010
Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritisNicolino Ruperto, Daniel J Lovell, Pierre Quartier, et al.
Annals of the Rheumatic Diseases|June 7, 2024
Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension studyHermine I Brunner, Jonathan D Akikusa, Eslam Al-Abadi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 3, 2018
IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic ArthritisVictoria L Arthur, Emily Shuldiner, Elaine F Remmers, et al.
Minerva Urology and Nephrology|September 25, 2024
Oncologic surveillance after surgical treatment for clinically localized kidney cancer: UroCCR study n. 129Alberto Martini, Jean-Christophe Bernhard, Ugo G Falagario, et al.
Pageof 55